Cargando…
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment
BACKGROUND: Defective copper regulation is implicated as a causative mechanism of organ damage in diabetes. Treatment with trientine, a divalent-copper-selective chelator, improves arterial and renal structure/function in diabetes, wherein it also ameliorates left-ventricular (LV) hypertrophy. Howev...
Autores principales: | Lu, Jun, Pontré, Beau, Pickup, Stephen, Choong, Soon Y, Li, Mingming, Xu, Hong, Gamble, Gregory D, Phillips, Anthony RJ, Cowan, Brett R, Young, Alistair A, Cooper, Garth JS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602174/ https://www.ncbi.nlm.nih.gov/pubmed/23368770 http://dx.doi.org/10.1186/1475-2840-12-28 |
Ejemplares similares
-
Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats
por: Zhang, Lin, et al.
Publicado: (2013) -
Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
por: Zhang, Shaoping, et al.
Publicado: (2014) -
Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022) -
Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes
por: Bakker, S. J. L., et al.
Publicado: (2009) -
Evaluation of left ventricular torsion by cardiovascular magnetic resonance
por: Young, Alistair A, et al.
Publicado: (2012)